Zusammenfassung
Auf der Suche nach einem biochemischen Parameter als Marker für die Hypertonie-Gefährdung wurde bei 172 gesunden Neugeborenen am 3. und 5. Lebenstag die Ausscheidung von PGE2 und von PGF2α gemessen und mit dem Blutdruck, der Elektrolytausscheidung sowie der Urinosmolalität verglichen. Daneben wurde der Blutdruck der Neugeborenen in Beziehung gesetzt zum Blutdruck der Mutter und zur Hypertonie-Anamnese in den Familien der Eltern.
Die PGE2-Ausscheidung stieg von 0,7 ng/mg Kreatinin am 3. Tag auf 1,5 am 5. Tag (p<0,001), während die PGF2α-Exkretion bei 2 ng/mg Kreatinin konstant blieb. Es bestand eine inverse Korrelation zwischen PGE2 und der Urinosmolalität (p<0,001), während die Kalium-Ausscheidung positiv zur PGF2α-Exkretion korreliert war (p<0,001). Am 5. Lebenstag war der systolische Blutdruck der Neugeborenen signifikant korreliert zu der PGF2α-Ausscheidung (p<0,05). Es bestand weiterhin eine positive Korrelation des systolischen Blutdrucks der Neugeborenen zum systolischen Blutdruck der Mütter (p<0,05). Der Blutdruck bei Neugeborenen mit Hypertonie in der Familienanamnese war bereits in der ersten Lebenswoche signifikant höher als der Blutdruck bei Kindern ohne Hypertonie bei Eltern und/oder Großeltern.
Die Untersuchungen deuten darauf hin, daß beim Neugeborenen renale Prostaglandine bei der Regulation der Urinosmolalität und der Kalium-Ausscheidung beteiligt sind. Die positive Korrelation zwischen PGF2α-Ausscheidung und Blutdruck wird als möglicher Marker eines genetisch determinierten Einflusses des renalen PG-Systems auf die Blutdruckregulation gedeutet.
Summary
We studied the excretion of prostaglandin (PG) E2 and of PGF2α in 172 healthy newborns during the first week of life to detect possible biochemical markers for the individual susceptibility to hypertension. PG excretion was compared to urinary electrolytes, urinary osmolality, and blood pressure. In addition, blood pressure of the newborns was related to the blood pressure of the mothers and to the history of hypertension in parents and/or grandparents.
PGE2-excretion increased from 0.7 ng/mg creatinine on the third day to 1.5 ng on the fifth day of life (p<0.001) while PGF2α excretion remained unchanged at 2 ng/mg creatinine. PGE2 (but not PGF2α) was inversely correlated to urinary osmolality (p<0.001) while urinary potassium was positively correlated to PGF2α (p<0.001). On the fifth day of life systolic blood pressure of the newborns was correlated to PGF2α-excretion and to systolic blood pressure of the mother (p<0.05). Blood pressure was significantly higher in newborns with a history of hypertension in parents or grandparents than in those without hypertension in relatives (p<0.02).
The data suggest that renal PG:s are involved in the regulation of urinary osmolality and potassium excretion in the neonate. The positive correlation between PGF2α excretion and blood pressure may indicate a genetically determined PG-related renal influence on the level of systemic blood pressure.
References
Abe K, Yasujima M, Chiba S, Irokawa N, Ito T, Yoshinaga K (1977) Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 14:513–521
Ahnfelt-Rønne I, Arrigoni-Martelli E (1978) Increased PGF2α synthesis in renal papilla of spontaneously hypertensive rats. Biochem Pharmacol 27:2363–2367
Aiken JW, Vane JR (1972) Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 184:678–687
Armstrong JM, Blackwell GJ, Flower RJ, McGiff JC, Mullane KM, Vane JR (1976) Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature 260:582–586
Berl T, Raz A, Wald H, Horowitz J, Czaczkes W (1977) Prostaglandin synthesis inhibition and the action of vasopressin: Studies in man and rat. Am J Physiol 232:F529-F537
Bianchi G, Cusi D, Gatti M, Lupi GP, Ferrari P, Barlassima C, Picotti GB, Bracchi G, Colombo G, Gori D, Velis O, Mazzei D (1979) A renal abnormality as a possible cause of “essential hypertension”. Lancet 1:173–177
Brody MJ, Kadowitz PJ (1974) Prostaglandins as modulators of the autonomic nervous system. Fed Proc 33:48–60
Ducharme DW, Weeks JR, Montgomery RG (1968) Studies on the mechanism of the hypertensive effect of prostaglandin F2α. J Pharmacol Exp Ther 160:1–10
Dunn MJ, Hood VL (1977) Prostaglandins and the kidney. Am J Physiol 233:F169-F184
Frölich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins, identification and origin. J Clin Invest 55:763–770
Galvez OG, Bay WH, Roberts BW, Ferris TF (1977) The hemodynamic effects of potassium deficiency in the dog. Circ Res 40:I-11–I-16
Larsson C, Änggard E (1972) Regional difference in the formation and metabolism of prostaglandins in the rabbit kidney. Eur J Pharmacol 21:30–36
Lee YH, Rosner B, Gould JB, Lowe EW, Kass EH (1976) Familial aggregation of blood pressures of newborn infants and their mothers. Pediatrics 58:722–729
McGiff JC, Itskovitz HD, Terragno A, Wong PYK (1976) Modulation and mediation of the action of the renal kallikreinkinin system by prostaglandins. Fed Proc 35:175–180
Papanicolaou N, Lefkos N, Safar M, Paris M, Bariety J, Milliez M (1976) Direct relationship between urinary prostaglandin E and sodium excretion in essential hypertensive patients. Experientia 32:1280–1281
Pomarède R, Moriette G, Czernichow P, Relier J-P (1978) Etude de la vasopressine plasmatique chez les enfants prématurés soumis a la ventilation artificielle. Arch Franç Pediat [Suppl] 38:75
Scherer B, Siess W, Weber PC (1977) Radioimmunological and biological measurement of prostaglandins in rabbit urine: Decrease of PGE2 excretion at high NaCl intake. Prostaglandins 13:1127–1139
Scherer B, Schnermann J, Sofroniev M, Weber PC (1978) Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: Effect on PG-excretion by PG-synthetase inhibitors, laparotomy and furosemide. Prostaglandins 15:255–266
Scherer B, Weber PC (1979) Time-dependent changes in prostaglandin excretion in response to frusemide in man. Clin Sci 56:77–81
Scherer B, Held E, Lange HH, Weber PC (1979) Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension. Klin Wochenschr 57:567–573
De Swiet M, Fancourt R, Peto J (1975) Systolic blood pressure variation during the first 6 days of life. Clin Sci Mol Med 49:557–561
De Swiet M, Fayers P, Shinebourne EA (1976) Blood pressure survey in a population of newborn infants. Br Med J 2:9–11
Tan SY, Sweet P, Mulrow PJ (1978) Impaired renal production of prostaglandin E2. A newly identified lesion in human essential hypertension. Prostaglandins 15:139–150
Terragno NA, McGiff JC, Terragno A (1978) Prostacyclin (PGI2) production by renal blood vessels. Relationship to an endogenous prostaglandin synthesis inhibitor. Clin Res 26:545A
Walker LA, Whorton AR, Smigel M, France R, Frölich JC (1978) Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol 235:F180-F185
Weber PC, Larsson C, Scherer B (1977) Prostaglandin-E2-9-keto-reductase as a mediator of salt-intake related prostaglandin-renin interaction. Nature 266:65–66
Weber PC, Scherer B, Lange HH, Held E, Schnermann J (1978) Renal prostaglandins and renin release: Relationship to regulation of electrolyte excretion and blood pressure. In: Proc. VIIth International Congress of Nephrology, Montreal, 1978. Karger, Basel, pp 99–106
Zinner SH, Margolius HS, Rosner B, Keiser HR, Kass EH (1976) Familial aggregation of urinary kallikrein concentration in childhood: Relation to blood pressure, race and urinary electrolytes. Am J Epidemiol 104:124–132
Zinner SH, Margolius HS, Rosner B, Kass EH (1978) Stability of blood pressure rank and urinary kallikrein concentration in childhood: An eight-year follow-up. Circulation 58:908–915
Zusman RM, Keiser HR, Handler JS (1977) Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder: Effect on water flow. J Clin Invest 60:1339–1347
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft (Sche 118/3–5)
Rights and permissions
About this article
Cite this article
Scherer, B., Friedmann, B., Dumbs, A. et al. Urinary prostaglandins in human neonates: Relationship to kidney function and blood pressure. Klin Wochenschr 58, 449–455 (1980). https://doi.org/10.1007/BF01476799
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01476799